Evidence map›Paper›PMID 34524527›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

The use of patient-reported outcomes in routine cancer care: preliminary insights from a multinational scoping survey of oncology practitioners.

Yin Ting Cheung, Alexandre Chan, Andreas Charalambous, H S Darling, Lawson Eng, Lisa Grech, Corina J G van den Hurk, Deborah Kirk, Sandra A Mitchell, Dagmara Poprawski and 4 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07787806 (A Randomized Controlled, Type 1 Hybrid Effectiveness-implementation Trial Study to Compare the Effectiveness of a Patient-Reported Outcomes), which is not on this map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07787806 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Randomized Controlled, Type 1 Hybrid Effectiveness-implementation Trial Study to Compare the Effectiveness of a Patient-Reported Outcomes (PRO)-Driven Culturally Grounded Supportive Care Navigation in Reducing Healthcare Disparities Among Hispanic/Latinx Patients Receiving Anticancer Therapies

TypeinterventionalSponsorUniversity of California, IrvineRan2026 to 2028Enrolled72ConditionsCancerArmsPatient-Reported Outcomes (PRO)-driven supportive care navigation
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Trial
  4. Review
  5. Implementation of an ePRO-based system supporting treatment readiness assessments in lung cancer care: a mixed-methods study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  6. From framework to practice: applying the proteus-practice framework to learn lessons for integrating PROs in clinical care.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Customizing workflows for electronic patient-reported outcome (ePRO) symptom monitoring using the action, actor, context, target, time (AACTT) framework.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 14 institutions in 10 countries.

Yin Ting CheungSchool of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Alexandre ChanSchool of Pharmacy & Pharmaceutical Sciences, Department of Clinical Pharmacy Practice, University of California, Irvine, LA, USA.
Andreas CharalambousDepartment of Nursing, Cyprus University of Technology, Limassol, Cyprus.
H S DarlingDepartment of Medical Oncology, Command Hospital Air Force, Bangalore, India.
Lawson EngDivision of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre/University Health Network, University of Toronto, Toronto, Canada.
Lisa GrechSchool of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Medicine Monash Health, Monash University, Melbourne, Australia.
Corina J G van den HurkR&D Department, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Deborah KirkSchool of Nursing and Midwifery, Edith Cowan University, Joondalup, WA, Australia.
Sandra A MitchellDivision of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Dagmara PoprawskiDepartment of Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Kingdom of Saudi Arabia.
Elke RammantDepartment of Human Structure and Repair, Ghent University, Ghent, Belgium.
Imogen RamseyRosemary Bryant AO Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, Australia.
Margaret I FitchBloomberg Faculty of Nursing, University of Toronto, 207 Chisholm Ave, Toronto, ON, Canada. marg.i.fitch@gmail.com.
Raymond J ChanCaring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, South Australia, 5042, Australia. Raymond.Chan@flinders.edu.au.ORCID http://orcid.org/0000-0003-0248-7046
Chinese University of Hong Kong · HKCommand Hospital Air Force · INEdith Cowan University · AUFlinders University · AUGhent University · BEKing Faisal Specialist Hospital & Research Centre · SANational Cancer Institute · USNetherlands Comprehensive Cancer Organisation · NLThe University of Melbourne · AUUniversity Health Network · CAUniversity of California, Irvine · USUniversity of South Australia · AUUniversity of Toronto · CAUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere exists scant evidence on the optimal approaches to integrating patient-reported outcomes (PROs) in clinical practice. This study gathered oncology practitioners' experiences with implementing PROs in cancer care.

methodsBetween December 2019 and June 2020, we surveyed practitioners who reported spending > 5% of their time providing clinical care to cancer patients. Respondents completed an online survey describing their experiences with and barriers to using PROs in clinical settings.

resultsIn total, 362 practitioners (physicians 38.7%, nurses 46.7%, allied health professionals 14.6%) completed the survey, representing 41 countries (Asia-Pacific 42.5%, North America 30.1%, Europe 24.0%, others 3.3%). One quarter (25.4%) identified themselves as "high frequency users" who conducted PRO assessments on > 80% of their patients. Practitioners commonly used PROs to facilitate communication (60.2%) and monitor treatment responses (52.6%). The most commonly reported implementation barriers were a lack of technological support (70.4%) and absence of a robust workflow to integrate PROs in clinical care (61.5%). Compared to practitioners from high-income countries, more practitioners in low-middle income countries reported not having access to a local PRO expert (P < .0001) and difficulty in identifying the appropriate PRO domains (P = .006). Compared with nurses and allied health professionals, physicians were more likely to perceive disruptions in clinical care during PRO collection (P = .001) as an implementation barrier.

conclusionsOnly a quarter of the surveyed practitioners reported capturing PROs in routine clinical practice. The implementation barriers to PRO use varied across respondents in different professions and levels of socioeconomic resources. Our findings can be applied to guide planning and implementation of PRO collection in cancer care.

Indexed as

Medical OncologyNeoplasmsAllied Health PersonnelHumansPatient Reported Outcome MeasuresSurveys and QuestionnairesPatient-centered carePatient-reported outcome measuresPatient-reported outcomesPROPROM

Identifiers

PMID34524527
PMCPMC8440726
OpenAlexW3199965611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.